Clinical efficacy of piracetam in cognitive impairment: a meta-analysis
Review of earlier studies · 2002
- What was studied
- 19 double-blind placebo comparisons in older patients with cognitive impairment
- Main finding
- Reported a favorable pooled clinical global impression of change. This differs from the memory-specific outcome in the 2024 analysis.
Study data at a glance
- Participants or experimental model
- 19 double-blind placebo comparisons in older patients with cognitive impairment
- Reported results
- Reported a favorable pooled clinical global impression of change. This differs from the memory-specific outcome in the 2024 analysis.
Study limitations and source details
Study limitations
- Several authors were affiliated with UCB; the search included the manufacturer’s document database.
- Older diagnostic definitions and outcome measures varied.
- A review is not independent replication of its underlying trials.
Source details
University-hosted PDF: title page, abstract and study-selection methods checked; full risk-of-bias reassessment pending.
Sources checked
Citation
T. Waegemans, C. R. Wilsher, A. Danniau, S. H. Ferris, A. Kurz, B. Winblad. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis Dementia and Geriatric Cognitive Disorders 13:217–224